BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27208904)

  • 1. Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity.
    Kudo-Saito C; Fuwa T; Kawakami Y
    Eur J Cancer; 2016 Jul; 62():54-61. PubMed ID: 27208904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4
    He K; Liu P; Xu LX
    Cell Death Dis; 2017 Mar; 8(3):e2703. PubMed ID: 28333145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
    Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions.
    Redondo P; del Olmo J; López-Diaz de Cerio A; Inoges S; Marquina M; Melero I; Bendandi M
    J Invest Dermatol; 2007 Jul; 127(7):1673-80. PubMed ID: 17380112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal Expression of Activated Leukocyte Cell Adhesion Molecule Promotes Lung Tumor Growth and Metastasis.
    Willrodt AH; Beffinger M; Vranova M; Protsyuk D; Schuler K; Jadhav M; Heikenwalder M; van den Broek M; Borsig L; Halin C
    Am J Pathol; 2017 Nov; 187(11):2558-2569. PubMed ID: 28822802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
    Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
    Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of eosinophils in mediating the anti-tumour effect of cryo-thermal treatment.
    Jia S; Li W; Liu P; Xu LX
    Sci Rep; 2019 Sep; 9(1):13214. PubMed ID: 31519961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A(2B) receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells.
    Kaji W; Tanaka S; Tsukimoto M; Kojima S
    J Toxicol Sci; 2014 Apr; 39(2):191-8. PubMed ID: 24646699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
    Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors.
    Morosi LG; Piperno GM; López L; Amadio R; Joshi S; Rustighi A; Del Sal G; Benvenuti F
    Oncoimmunology; 2024; 13(1):2367843. PubMed ID: 38887373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunction.
    Kudo-Saito C; Fuwa T; Murakami K; Kawakami Y
    Cancer Res; 2013 Oct; 73(20):6185-93. PubMed ID: 23966294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation.
    Cerqueira MA; Ferrari KL; de Mattos AC; Monti CR; Reis LO
    World J Urol; 2020 Mar; 38(3):673-680. PubMed ID: 31263944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent induction of antitumor immunity by combining cryo-thermal ablation with immune checkpoint inhibitors in hepatocellular carcinoma.
    Qian L; Xie L; Zhu Y; Huang C; Meng Z
    Liver Int; 2024 Mar; 44(3):723-737. PubMed ID: 38111027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
    Yu Y; Huang R; Zong X; He X; Mo W
    BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.